Index
1 Facial Injectables Market Overview
1.1 Facial Injectables Product Overview
1.2 Facial Injectables Market Segment by Type
1.2.1 Botox
1.2.2 Dermal Fillers
1.2.3 Other
1.3 Global Facial Injectables Market Size by Type
1.3.1 Global Facial Injectables Market Size Overview by Type (2018-2029)
1.3.2 Global Facial Injectables Historic Market Size Review by Type (2018-2023)
1.3.3 Global Facial Injectables Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Facial Injectables Sales Breakdown by Type (2018-2023)
1.4.2 Europe Facial Injectables Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Facial Injectables Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Facial Injectables Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Facial Injectables Sales Breakdown by Type (2018-2023)
2 Global Facial Injectables Market Competition by Company
2.1 Global Top Players by Facial Injectables Sales (2018-2023)
2.2 Global Top Players by Facial Injectables Revenue (2018-2023)
2.3 Global Top Players by Facial Injectables Price (2018-2023)
2.4 Global Top Manufacturers Facial Injectables Manufacturing Base Distribution, Sales Area, Product Type
2.5 Facial Injectables Market Competitive Situation and Trends
2.5.1 Facial Injectables Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Facial Injectables Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Facial Injectables as of 2022)
2.7 Date of Key Manufacturers Enter into Facial Injectables Market
2.8 Key Manufacturers Facial Injectables Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Facial Injectables Status and Outlook by Region
3.1 Global Facial Injectables Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Facial Injectables Historic Market Size by Region
3.2.1 Global Facial Injectables Sales in Volume by Region (2018-2023)
3.2.2 Global Facial Injectables Sales in Value by Region (2018-2023)
3.2.3 Global Facial Injectables Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Facial Injectables Forecasted Market Size by Region
3.3.1 Global Facial Injectables Sales in Volume by Region (2024-2029)
3.3.2 Global Facial Injectables Sales in Value by Region (2024-2029)
3.3.3 Global Facial Injectables Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Facial Injectables by Application
4.1 Facial Injectables Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Cosmetic Centers
4.1.4 Other
4.2 Global Facial Injectables Market Size by Application
4.2.1 Global Facial Injectables Market Size Overview by Application (2018-2029)
4.2.2 Global Facial Injectables Historic Market Size Review by Application (2018-2023)
4.2.3 Global Facial Injectables Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Facial Injectables Sales Breakdown by Application (2018-2023)
4.3.2 Europe Facial Injectables Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Facial Injectables Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Facial Injectables Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Facial Injectables Sales Breakdown by Application (2018-2023)
5 North America Facial Injectables by Country
5.1 North America Facial Injectables Historic Market Size by Country
5.1.1 North America Facial Injectables Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Facial Injectables Sales in Volume by Country (2018-2023)
5.1.3 North America Facial Injectables Sales in Value by Country (2018-2023)
5.2 North America Facial Injectables Forecasted Market Size by Country
5.2.1 North America Facial Injectables Sales in Volume by Country (2024-2029)
5.2.2 North America Facial Injectables Sales in Value by Country (2024-2029)
6 Europe Facial Injectables by Country
6.1 Europe Facial Injectables Historic Market Size by Country
6.1.1 Europe Facial Injectables Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Facial Injectables Sales in Volume by Country (2018-2023)
6.1.3 Europe Facial Injectables Sales in Value by Country (2018-2023)
6.2 Europe Facial Injectables Forecasted Market Size by Country
6.2.1 Europe Facial Injectables Sales in Volume by Country (2024-2029)
6.2.2 Europe Facial Injectables Sales in Value by Country (2024-2029)
7 Asia-Pacific Facial Injectables by Region
7.1 Asia-Pacific Facial Injectables Historic Market Size by Region
7.1.1 Asia-Pacific Facial Injectables Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Facial Injectables Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Facial Injectables Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Facial Injectables Forecasted Market Size by Region
7.2.1 Asia-Pacific Facial Injectables Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Facial Injectables Sales in Value by Region (2024-2029)
8 Latin America Facial Injectables by Country
8.1 Latin America Facial Injectables Historic Market Size by Country
8.1.1 Latin America Facial Injectables Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Facial Injectables Sales in Volume by Country (2018-2023)
8.1.3 Latin America Facial Injectables Sales in Value by Country (2018-2023)
8.2 Latin America Facial Injectables Forecasted Market Size by Country
8.2.1 Latin America Facial Injectables Sales in Volume by Country (2024-2029)
8.2.2 Latin America Facial Injectables Sales in Value by Country (2024-2029)
9 Middle East and Africa Facial Injectables by Country
9.1 Middle East and Africa Facial Injectables Historic Market Size by Country
9.1.1 Middle East and Africa Facial Injectables Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Facial Injectables Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Facial Injectables Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Facial Injectables Forecasted Market Size by Country
9.2.1 Middle East and Africa Facial Injectables Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Facial Injectables Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Allergan Facial Injectables Products Offered
10.1.5 Allergan Recent Development
10.2 Merz Aesthetics
10.2.1 Merz Aesthetics Company Information
10.2.2 Merz Aesthetics Introduction and Business Overview
10.2.3 Merz Aesthetics Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merz Aesthetics Facial Injectables Products Offered
10.2.5 Merz Aesthetics Recent Development
10.3 Prollenium Medical Technologies
10.3.1 Prollenium Medical Technologies Company Information
10.3.2 Prollenium Medical Technologies Introduction and Business Overview
10.3.3 Prollenium Medical Technologies Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Prollenium Medical Technologies Facial Injectables Products Offered
10.3.5 Prollenium Medical Technologies Recent Development
10.4 Bloomega BioTechnology
10.4.1 Bloomega BioTechnology Company Information
10.4.2 Bloomega BioTechnology Introduction and Business Overview
10.4.3 Bloomega BioTechnology Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bloomega BioTechnology Facial Injectables Products Offered
10.4.5 Bloomega BioTechnology Recent Development
10.5 Galderma
10.5.1 Galderma Company Information
10.5.2 Galderma Introduction and Business Overview
10.5.3 Galderma Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Galderma Facial Injectables Products Offered
10.5.5 Galderma Recent Development
10.6 Ipsen Group
10.6.1 Ipsen Group Company Information
10.6.2 Ipsen Group Introduction and Business Overview
10.6.3 Ipsen Group Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ipsen Group Facial Injectables Products Offered
10.6.5 Ipsen Group Recent Development
10.7 Suneva Medical
10.7.1 Suneva Medical Company Information
10.7.2 Suneva Medical Introduction and Business Overview
10.7.3 Suneva Medical Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Suneva Medical Facial Injectables Products Offered
10.7.5 Suneva Medical Recent Development
10.8 Polymekon
10.8.1 Polymekon Company Information
10.8.2 Polymekon Introduction and Business Overview
10.8.3 Polymekon Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Polymekon Facial Injectables Products Offered
10.8.5 Polymekon Recent Development
10.9 Visionmed
10.9.1 Visionmed Company Information
10.9.2 Visionmed Introduction and Business Overview
10.9.3 Visionmed Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Visionmed Facial Injectables Products Offered
10.9.5 Visionmed Recent Development
10.10 Syneron
10.10.1 Syneron Company Information
10.10.2 Syneron Introduction and Business Overview
10.10.3 Syneron Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Syneron Facial Injectables Products Offered
10.10.5 Syneron Recent Development
10.11 Medytox
10.11.1 Medytox Company Information
10.11.2 Medytox Introduction and Business Overview
10.11.3 Medytox Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Medytox Facial Injectables Products Offered
10.11.5 Medytox Recent Development
10.12 AQTIS Medical
10.12.1 AQTIS Medical Company Information
10.12.2 AQTIS Medical Introduction and Business Overview
10.12.3 AQTIS Medical Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.12.4 AQTIS Medical Facial Injectables Products Offered
10.12.5 AQTIS Medical Recent Development
10.13 ColBar LifeScience
10.13.1 ColBar LifeScience Company Information
10.13.2 ColBar LifeScience Introduction and Business Overview
10.13.3 ColBar LifeScience Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.13.4 ColBar LifeScience Facial Injectables Products Offered
10.13.5 ColBar LifeScience Recent Development
10.14 SciVision Biotech
10.14.1 SciVision Biotech Company Information
10.14.2 SciVision Biotech Introduction and Business Overview
10.14.3 SciVision Biotech Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.14.4 SciVision Biotech Facial Injectables Products Offered
10.14.5 SciVision Biotech Recent Development
10.15 Hangzhou Techderm Biological Products
10.15.1 Hangzhou Techderm Biological Products Company Information
10.15.2 Hangzhou Techderm Biological Products Introduction and Business Overview
10.15.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Hangzhou Techderm Biological Products Facial Injectables Products Offered
10.15.5 Hangzhou Techderm Biological Products Recent Development
10.16 Qufu Guanglong Biochem
10.16.1 Qufu Guanglong Biochem Company Information
10.16.2 Qufu Guanglong Biochem Introduction and Business Overview
10.16.3 Qufu Guanglong Biochem Facial Injectables Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Qufu Guanglong Biochem Facial Injectables Products Offered
10.16.5 Qufu Guanglong Biochem Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Facial Injectables Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Facial Injectables Industrial Chain Analysis
11.4 Facial Injectables Market Dynamics
11.4.1 Facial Injectables Industry Trends
11.4.2 Facial Injectables Market Drivers
11.4.3 Facial Injectables Market Challenges
11.4.4 Facial Injectables Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Facial Injectables Distributors
12.3 Facial Injectables Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer